北京大学医学部机构知识库
Advanced  
IR@PKUHSC  > 北京大学第二临床医学院  > 期刊论文
学科主题: 临床医学
题名:
Efficacy and Safety of Traditional Chinese Medicine for Diabetes: A Double-Blind, Randomised, Controlled Trial
作者: Ji, Linong1; Tong, Xiaolin2; Wang, Hongyuan3; Tian, Haoming4; Zhou, Huimin5; Zhang, Lili6; Li, Qifu7; Wang, Yizhong8; Li, Hongmei9; Liu, Min10; Yang, Hongjie11; Gao, Yanbin12; Li, Yan13; Li, Quanmin14; Guo, Xiaohui15; Yang, Gangyi16; Zhang, Zhongai17; Zhou, Zhiguang18; Ning, Guang19; Chen, Yingli1; Paul, Sanjoy20; Evidence-Based Med Res Xiaoke Pill
刊名: PLOS ONE
发表日期: 2013-02-27
DOI: 10.1371/journal.pone.0056703
卷: 8, 期:2
收录类别: SCI
文章类型: Article
WOS标题词: Science & Technology
类目[WOS]: Multidisciplinary Sciences
研究领域[WOS]: Science & Technology - Other Topics
关键词[WOS]: THERAPY
英文摘要:

Background: Treatment of diabetes mellitus with Traditional Chinese Medicine has a long history. The aim of this study is to establish the safety and efficacy of traditional Chinese medicine combined with glibenclamide to treat type 2 diabetes mellitus.

Methods: In a controlled, double blind, multicentre non-inferiority trial, 800 patients with unsatisfactory glycemic control (fasting glucose 7-13 mmol/L and HbA1c 7-11%) were randomly assigned to receive Xiaoke Pill, a compound of Chinese herbs combined with glibenclamide, or Glibenclamide in two study groups - drug naive group, and patients previously treated with metformin monotherapy (metformin group). Outcome measures at 48 weeks were the incidence and rate of hypoglycemia, mean difference in HbA1c, and proportion of patients with HbA1c<6.5%.

Findings: In drug naive group, the total hypoglycemia rate and the mild hypoglycemic episode in the Xiaoke Pill arm were 38% (p = 0.024) and 41% (p = 0.002) less compared to Glibenclamide arm; in Metformin group, the average annual rate of hypoglycemia was 62% lower in Xiaoke Pill arm (p = 0.003). Respective mean changes in HbA1c from baseline were -0.70% and -0.66% for Xiaoke Pill and Glibenclamide, with a between-group difference (95% CI) of -0.04% (-0.20, 0.12) in the drug naive group, and those in metformin group were -0.45% and -0.59%, 0.14% (-0.12, 0.39) respectively. The respective proportions of patients with a HbA1c level <6.5% were 26.6% and 23.4% in the drug naive group and 20.1% and 18.9% in the metformin group.

Interpretation: In patients with type 2 diabetes and inadequate glycaemic control, treatment with Xiaoke Pill led to significant reduction in risk of hypoglycemia and similar improvements in glycemic control after 48 weeks compared to Glibenclamide.

Trial Registration: Chinese Clinical Trial Register number, ChiCTR-TRC-08000074

语种: 英语
所属项目编号: 2011CB504001 ; 2006AA02A409
项目资助者: National Basic Research Program of China (973 program) ; National High Technology Research and Development Program (863 program) ; Guangzhou Zhongyi Pharmaceutical ; Eli Lilly ; Bristol-Myers Squibb ; Novartis ; Novo Nordisk ; Merck ; Bayer ; Takeda ; Sanofi-Aventis ; GlaxoSmithKline ; Roche ; Johnson Johnson ; boehingeringelheim
WOS记录号: WOS:000315519000033
Citation statistics:
内容类型: 期刊论文
URI标识: http://ir.bjmu.edu.cn/handle/400002259/67157
Appears in Collections:北京大学第二临床医学院_期刊论文

Files in This Item:

There are no files associated with this item.


作者单位: 1.Peking Univ, Peoples Hosp, Beijing 100871, Peoples R China
2.China Acad Chinese Medicial Sci, Guanganmen Hosp, Beijing, Peoples R China
3.Peking Univ, Sch Publ Hlth, Beijing 100871, Peoples R China
4.Sichuan Univ, West China Hosp, Chengdu 610064, Peoples R China
5.Hebei Med Univ, Hosp 1, Shijiazhuang, Peoples R China
6.China Aerosp Corp, Cent Hosp, Beijing, Peoples R China
7.China Meitan Gen Hosp, Beijing, Peoples R China
8.PLA Second Artillery, Gen Hosp, Beijing, Peoples R China
9.Peking Univ Tradit Chinese & Western Med, Affiliated Hosp 3, Beijing, Peoples R China
10.Chongqing Med Univ, Affiliated Hosp 1, Chongqing, Peoples R China
11.Guangzhou Univ Tradit Chinese Med, Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China
12.Shanghai Univ Tradit Chinese Med, Yueyang Hosp Integrated Tradit Chinese & Western, Shanghai, Peoples R China
13.Beijing Univ Tradit Chinese Med, Dongfang Hosp, Beijing, Peoples R China
14.Zhongshan Univ, Sun Yai Sen Mem Hosp, Zhongshan, Peoples R China
15.Peking Univ, Hosp 1, Beijing 100871, Peoples R China
16.Chongqing Med Univ, Affiliated Hosp 2, Chongqing, Peoples R China
17.Cent S Univ, Xiangya Hosp 2, Changsha, Hunan, Peoples R China
18.Shanghai Jiao Tong Univ, Ruijin Hosp, Shanghai 200030, Peoples R China
19.Univ Queensland, Queensland Clin Trials & Biostat Ctr, Sch Populat Hlth, Brisbane, Qld 4072, Australia
20.Nanjing Hosp Tradit Chinese Med, Nanjing, Jiangsu, Peoples R China

Recommended Citation:
Ji, Linong,Tong, Xiaolin,Wang, Hongyuan,et al. Efficacy and Safety of Traditional Chinese Medicine for Diabetes: A Double-Blind, Randomised, Controlled Trial[J]. PLOS ONE,2013,8(2).
Service
Recommend this item
Sava as my favorate item
Show this item's statistics
Export Endnote File
Google Scholar
Similar articles in Google Scholar
[Ji, Linong]'s Articles
[Tong, Xiaolin]'s Articles
[Wang, Hongyuan]'s Articles
CSDL cross search
Similar articles in CSDL Cross Search
[Ji, Linong]‘s Articles
[Tong, Xiaolin]‘s Articles
[Wang, Hongyuan]‘s Articles
Related Copyright Policies
Null
Social Bookmarking
Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit
所有评论 (0)
暂无评论
 
评注功能仅针对注册用户开放,请您登录
您对该条目有什么异议,请填写以下表单,管理员会尽快联系您。
内 容:
Email:  *
单位:
验证码:   刷新
您在IR的使用过程中有什么好的想法或者建议可以反馈给我们。
标 题:
 *
内 容:
Email:  *
验证码:   刷新

Items in IR are protected by copyright, with all rights reserved, unless otherwise indicated.

 

 

Valid XHTML 1.0!
Copyright © 2007-2017  北京大学医学部 - Feedback
Powered by CSpace